Phoenix Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Phoenix Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-807	Closed	-$60K	–	135
2021 Q3	$60K	Hold	807	–	–	0.04%	181
2021 Q2	$73K	Hold	807	–	–	0.05%	166
2021 Q1	$72K	Buy	807 +57	+8%	+$5.65K	0.06%	167
2020 Q4	$70K	Buy	+750	New	+$59.8K	0.05%	171

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Phoenix Wealth Advisors's ARKG Position: Q4 2021 in Review

Phoenix Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 807 shares — an estimated $60K sold.

Phoenix Wealth Advisors first reported a position in ARKG in Q4 2020 and held it in 4 quarters. The position peaked at $73K in Q2 2021. 462 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

Phoenix Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
Phoenix Wealth Advisors sold 807 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $60K.
Phoenix Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 4 quarters.
Phoenix Wealth Advisors's ARK Genomic Revolution ETF position peaked at $73K in Q2 2021.
462 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Phoenix Wealth Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.